Navigation Links
New Drug May Help Those Who Can't Take Statins
Date:11/5/2012

MONDAY, Nov. 5 (HealthDay News) -- An experimental drug may help patients who can't tolerate statins lower their cholesterol, a new Australian study suggests.

The 12-week, phase 2 clinical trial was conducted at 33 international sites and included adults who suffered muscle problems when taking statins, a class of cholesterol-lowering drugs that includes Crestor and Lipitor. They received injections of a placebo or different doses of AMG145, which is a human monoclonal antibody.

Human monoclonal antibodies are naturally occurring human antibodies that are genetically altered in a laboratory, cloned in large numbers and introduced into the patient to target disease sites.

The patients who received AMG145 had 41 percent to 63 percent reductions in "bad" (LDL) cholesterol and did not experience significant muscle-related side effects, said study leader Dr. David Sullivan, of the Royal Prince Alfred Hospital in Australia, and colleagues.

The reductions in LDL cholesterol seen in these patients were comparable to those that occur in patients taking the highest doses of the most effective statins, the researchers added.

One expert found the results intriguing.

"The most interesting aspect of this study is use of a novel approach using monoclonal antibodies -- a subtype of antibodies -- in the management of elevated LDL cholesterol," said Dr. Kenneth Ong, acting chief of cardiology at the Brooklyn Hospital Center.

"In this phase 2 study, the results are certainly impressive and warrant further investigation," Ong said. "Of note is the reduction in the number of myalgias (muscle pains) for patients compared to the number of myalgias experienced by people taking statins. If larger trials and longer durations of observation confirm these initial findings, many patients whose LDL cholesterol are otherwise untreated or under-treated could benefit."

Another expert agreed.

"For those patients wi
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Obese Workers Health Care Costs Top Those of Smokers
2. Experimental Gel May Help Those With Advanced Parkinsons
3. Screening for Lung Cancer Might Benefit Those at Highest Risk
4. Cancer screening rates comparable for those with and without rheumatoid arthritis
5. Protecting the hearts of those waiting for kidney and liver transplants
6. Drug shown to improve memory in those with Down syndrome
7. Preventive Measures Pay Off for Those at Risk of Stroke
8. Home-Based Care Teams Offer Help for Those With Dementia
9. Alcohol Poses Serious Risks for Those With Diabetes
10. Those who are covered, recover
11. Working Moms Report Better Health Than Those Who Stay Home
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Drug May Help Those Who Can't Take Statins
(Date:4/18/2014)... Hopkins University School of Medicine researchers have been awarded ... diabetes, Novo Nordisk announced this month. Of the 110 ... Obesity Biologics Science Forum Program, only four projects were ... researchers. They are Jonathan Powell, M.D., Ph.D.; G. William ... Jonathan Powell, a professor of oncology, will use his ...
(Date:4/18/2014)... Benaroya Research Institute at Virginia Mason (BRI) recently received ... in metastatic breast cancer reduces both the growth of ... scientists have found in models of the disease that ... 80 percent and can keep the tumor from metastasizing ... grant comes from the National Cancer Institute of the ...
(Date:4/18/2014)... 2014) ― A new study in the American ... health-related Google searches reveals a recurring pattern that could ... , Investigators from San Diego State University, the Santa ... analyzed "healthy" Google searches (searches that included the term ... in the U.S. from 2005 to 2012. They found ...
(Date:4/18/2014)... scientists could lead to potential new treatments for breaking ... , Fibrosis, or scarring, is a hallmark of ... lungs can lead to serious organ damage and, in ... options centers on findings made by Swati Bhattacharyya, PhD, ... that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... of chronic inflammation in non-cancerous prostate tissue may have ... than those with no inflammation, according to results of ... Hopkins Kimmel Cancer Center. , The link between persistent ... so-called high-grade prostate cancer those with a Gleason ... of the most aggressive and rapidly growing prostate cancers. ...
Breaking Medicine News(10 mins):Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New research shows people are thinking about their health early in the week 2Health News:New clues on tissue scarring in scleroderma 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3
... claiming that the she admitted to being an alcoholic. ... was made up and not written by her. ... Contactmusic quoted Allen, as saying. ,The Smile singer revealed ... was misinterpreted by someone and was spread wrongly. ,"I ...
... smoking rate has shown a decline, thanks to the comprehensive ... statistics in the 2006 report shows a decline in ... ,Over the past year, smoking decreased among men (from ... These large declines followed a year-long ad campaign aimed at ...
... detecting and measuring all known forms of hepatitis B ... patient therapy. ,Abbott and Celera, an Applera ... marking for a real-time PCR (polymerase chain reaction) test ... allowing the test to be marketed in the European ...
... Purdue university researchers has found a new modified drug for ... clinical trials. ,Millions of people suffer from ... Arun Ghosh, the Purdue professor who led the creation of ... could be the first disease-modifying therapy. It may be able ...
... Pennsylvania School of Medicine have identified proteins in the rod ... discovery of the genetic causes of a host of ... understanding of what goes wrong at the most basic level ... ,Specifically, they have identified and measured the types and ...
... study, published in The American Journal of Gastroenterology, indicates ... and 304 patients has confirmed that polyethylene (PEG) ... even elderly patients can use the drug safely for ... few data were available regarding the long term treatment ...
Cached Medicine News:Health News:New York Records Decline in Smoking Rate 2Health News:Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe 2Health News:Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe 3Health News:Modified Drug Therapy for Alzheimers Disease 2Health News:Genetic Cause of Inherited Eye Diseases Identified 2
(Date:1/14/2014)... , a manufacturer of ergonomically designed laboratory equipment for ... Japan to sell and service the Hitachi ... will utilize its network of sales professionals throughout the ... offer assistance in application use, product benefits and features, options and ...
(Date:1/14/2014)... 2014   Oligomerix, Inc. , a privately held company ... disease (AD) and related neurodegenerative disorders, announced today the ... NY as of January 15, 2014 and ... York Medical College. Oligomerix, which is focused ...
(Date:1/14/2014)... 2014   Evidera , a leading provider of evidence-based ... for Drug Evaluation and Research (CDER), U.S. Food and ... document for a patient-reported outcome (PRO) measure in drug ... Tool [EXACT] for Measurement of Symptoms of Acute Bacterial ...
Breaking Medicine Technology:NuAire announces sales and service of Hitachi Koki centrifuges in North America 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
... Feb. 9, 2011 Telik, Inc. (Nasdaq: TELK ... will provide a corporate overview at the 13th Annual BIO ... February 15 at 3:00 p.m. Eastern time (12:00 p.m. Pacific ... archived webcast of the presentation will be available on the ...
... With its governmental markets still depressed, Allied Healthcare Products (Nasdaq: ... of fiscal year 2011 and improvement in its year-over-year performance. ... $117,000, or 1 cent per basic and diluted share, compared to ... For the first two quarters of the fiscal year, net income ...
Cached Medicine Technology:Allied Healthcare Products Reports Modest Profit for Quarter 2Allied Healthcare Products Reports Modest Profit for Quarter 3Allied Healthcare Products Reports Modest Profit for Quarter 4
For the quantitative determination of total cholesterol in serum....
Intended for the quantitative determination of total cholesterol in serum. Reaction: Endpoint. Reaction complete within five minutes. Wavelength: 500 nm. Linearity: 700 mg/dL (18.1 mmol/L). Single st...
... determination of Cholesterol in serum. ... 520 nm. Linearity: 500 mg/dl. ... simple 1:25 dilution and is ... 2-8 C. Liquid kit stability: ...
This 16-bit integrated and cooled system is a completely self contained unit built with a long list of standard features including all-electronic-variable transilluminator and EPI lighting....
Medicine Products: